The effect of rituximab on the quality of life of children with refractory nephrotic syndrome.
Toshiyuki TakahashiTakayuki OkamotoIsao YokotaYasuyuki SatoAsako HayashiYasuhiro UedaHayato AoyagiMichihiko UenoNorio KobayashiKimiaki UetakeMasanori NakanishiTadashi ArigaPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2021)
Our treatment protocol showed a significant improvement of QOL in patients with refractory NS. Although the risk of the RTX treatment should be considered, the treatment is useful for patients with refractory NS.